Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC)
in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors …

Background Several risk scores have been recently developed to predict hepatocellular
carcinoma (HCC) in chronic hepatitis B (CHB) patients. We systematically assessed the …

Background Patients on oral antiviral (OAV) therapy remain at hepatocellular carcinoma
(HCC) risk. Risk prediction tools distinguishing treated patients with residual HCC risk are …

Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …

Background & Aims The aim of our study was to characterize the performance of
hepatocellular carcinoma (HCC) prediction models in chronic hepatitis B (CHB) patients …

Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection
remains a major health issue worldwide. HBV is highly infectious and may cause chronic …

Discussion Hepatocyte LCC is an age-and senescence-related phenomenon caused by
cellular replicative exhaustion.(1, 2) For instance, hepatocyte nuclear size increases …

Background and Aims Hepatic ischemia‐reperfusion (IR) injury is a major complication of
liver transplantation, resection, and hemorrhagic shock. Hypoxia is a key pathological event …

Methods Fifteen thousand one hundred eighty-seven treatment-naïve adult CHB patients
were identified to form the training cohort in this retrospective study. Individual fibrosis score …

Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers and
represents a global health challenge. Liver cancer ranks third in cancer-related mortality …